OUR PRODUCTS

MOBILE APPS

GENERAL INFO

DNLI

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Denali Therapeutics (DNLI) Earnings Date & Reports

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

DNLI is expected to report earnings to rise 6.57% to -76 cents per share on October 30

Denali Therapeutics DNLI Stock Earnings Reports

Q3'25

Est.

$-0.77

Q2'25

Missed

by $0.01

Q1'25

Missed

by $0.08

Q4'24

Beat

by $0.17

Q3'24

Missed

by $0.03

The last earnings report on August 11 showed earnings per share of -72 cents, missing the estimate of -70 cents. With 1.13M shares outstanding, the current market capitalization sits at 1.92B.

View a ticker or compare two or three

Compare

DNLI

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For DNLI
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. DNLI showed earnings on August 11, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a biotechnology company

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

161 Oyster Point Boulevard

Phone

+1 650 866-8548

Employees

445

Web

https://www.denalitherapeutics.com